• Mashup Score: 27

    The European Commission’s Directorate-General for European Civil Protection and Humanitarian Aid Operations (ECHO) is supporting the work of the World Health Organization (WHO) to boost COVID-19 vaccination campaigns and increase coverage in 15 African countries.

    Tweet Tweets with this article
    • #VaccinEquity is essential to end the #COVID19 pandemic and save lives. We’re grateful for @eu_echo’s ongoing initiative, including €16 million contribution, to deliver vaccines and provide technical support to 15 countries in Africa. https://t.co/CKYXkV3epH

  • Mashup Score: 12

    The final phase 3 clinical data for CanSino Biologics’ adenovirus type 5 vector vaccine show that Ad5-nCoV is efficacious.1 However, emergency approval was granted in ten countries before data on its efficacy were available, even though other vaccines were already approved.1 If the results of the trial had been unfavourable, millions of people would have been vaccinated and granted a false sense…

    Tweet Tweets with this article
    • The consequences of vaccine access inequity are numerous & include vaccine approval before phase 3 trial results. @IsaacNunezs discusses the implications & #VaccinEquity as a moral imperative. https://t.co/267m8JT50X

  • Mashup Score: 6

    Immunisation against SARS-CoV-2 with mRNA vaccines remains the most effective way of preventing COVID-19-related morbidity and mortality. Medium-term data show that the efficacy of mRNA vaccination (two doses) is robust for up to 5–6 months, as supported by immunogenicity studies.1,2 Thereafter, the effectiveness of mRNA vaccines diminishes, and booster doses have been recommended for various…

    Tweet Tweets with this article
    • In this letter, @ProfAsmaKhalil and colleagues discuss booster doses in pregnancy and global #VaccinEquity, considering the strategies likely to be more effective in reducing #COVID19 complications. https://t.co/aavpDDVxqs

  • Mashup Score: 0

    Immunisation against SARS-CoV-2 with mRNA vaccines remains the most effective way of preventing COVID-19-related morbidity and mortality. Medium-term data show that the efficacy of mRNA vaccination (two doses) is robust for up to 5–6 months, as supported by immunogenicity studies.1,2 Thereafter, the effectiveness of mRNA vaccines diminishes, and booster doses have been recommended for various…

    Tweet Tweets with this article
    • In this letter, @ProfAsmaKhalil and colleagues discuss #booster doses in pregnancy and global #VaccinEquity, considering the strategies likely to be more effective in reducing #COVID19 complications. https://t.co/E7xFa41nGL

  • Mashup Score: 32

    WHO, the Republic of Korea and the WHO Academy today announced the establishment of a global biomanufacturing training hub that will serve all low- and middle-income countries wishing to produce biologicals, such as vaccines, insulin, monoclonal antibodies and cancer treatments.

    Tweet Tweets with this article
    • I thank Ministers 🇰🇷 Kwon Deok-chul, 🇮🇩 @Menlu_RI, 🇦🇷 @carlavizzotti, 🇷🇸 Zlatibor Loncar, 🇻🇳 Nguyen Thanh Long for their commitment to #VaccinEquity. Our vision is that this initiative will pay dividends for many years to come and help to save many lives. https://t.co/ZPOmw5CQpm

    • Argentina and Brazil were the first countries to receive mRNA technology from the hub in SouthAfrica, joining the initiative in September 2021. Companies from those countries are already receiving training from the technology transfer hub. https://t.co/ZPOmw5CQpm #VaccinEquity